Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Durect plunges 33% on failed drug study
Durect plunges 33% on failed drug study
Durect plunges 33% on failed drug study
Submitted by
admin
on January 6, 2012 - 12:48pm
Source:
Marketwatch
News Tags:
Durect Corporation
post-surgical pain
Posidur
Headline:
Durect plunges 33% on failed drug study
Do Not Allow Advertisers to Use My Personal information
